| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Operating Activities | ||||||
Net loss | ||||||
-304,706 | -127,502 | -51,006 | -27,124 | |||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Share-based compensation expense | ||||||
21,144 | 7,733 | 5,418 | 1,078 | |||
Loss on early extinguishment of debt | ||||||
-1,501 | - | - | - | |||
Loss from remeasurement of development derivative liability | ||||||
-14,839 | -85 | 153 | - | |||
Non-cash lease expense | ||||||
355 | - | - | - | |||
Depreciation expense | ||||||
239 | - | - | - | |||
Amortization of debt discounts | ||||||
51 | - | - | - | |||
Amortization of term loan facility discounts | ||||||
104 | - | - | - | |||
Amortization of discounts for convertible notes, net of financing costs | ||||||
2,186 | - | - | - | |||
Accretion of discounts for promissory note | ||||||
- | 71 | 13 | - | |||
Accretion of discounts for term loan facility | ||||||
- | 582 | 11 | - | |||
Changes in operating assets and liabilities: | ||||||
Refundable research and development credit | ||||||
- | -299 | 50 | 408 | |||
Prepaid assets | ||||||
-4,531 | 19,275 | 3,927 | 873 | |||
Other current assets | ||||||
-287 | 309 | -10 | - | |||
Other assets | ||||||
322 | 978 | 51 | -68 | |||
Accounts payable | ||||||
-1,640 | 6,587 | 932 | 69 | |||
Accrued expenses | ||||||
50,453 | 2,234 | 1,798 | 368 | |||
Other liabilities | ||||||
-158 | - | - | - | |||
Net cash used in operating activities | ||||||
-211,135 | -131,240 | -46,595 | -26,003 | |||
Investing Activities | ||||||
Purchase of property and equipment | ||||||
1,693 | - | - | - | |||
Net cash used in investing activities | ||||||
-1,693 | - | - | - | |||
Financing Activities | ||||||
Deferred issuance costs | ||||||
- | 18 | - | - | |||
Proceeds from issuance of term loan, net of issuance costs | ||||||
- | - | 19,795 | - | |||
Proceeds from issuance of promissory note payable to an affiliate of stockholder | ||||||
- | - | -6,569 | - | |||
Proceeds from issuance of common stock, net of issuance costs | ||||||
109,581 | 131,194 | 150,062 | - | |||
Proceeds from development derivative liability | ||||||
120,000 | - | - | - | |||
Payments for capped call transactions and associated costs | ||||||
28,380 | - | - | - | |||
Proceeds from issuance of convertible notes, net of issuance costs | ||||||
212,912 | - | - | - | |||
Proceeds from issuance of stock options and warrants | ||||||
3,129 | 727 | 678 | - | |||
Proceeds from the issuance of common stock warrants | ||||||
- | - | 520 | - | |||
Repayment of promissory note | ||||||
7,000 | - | - | - | |||
Repayment of term loan facility | ||||||
21,701 | - | - | - | |||
Net cash provided by financing activities | ||||||
388,541 | 131,903 | 197,375 | 14,863 | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
4 | -38 | - | - | |||
Net increase in cash, cash equivalents and restricted cash | ||||||
175,717 | 624 | 150,780 | -11,140 | |||
Conversion of convertible preferred stock to common stock | ||||||
- | - | 111,802 | - | |||
Cash paid for Interest | ||||||
987 | 1,816 | 134 | - | |||
Equity component of convertible notes | ||||||
72,520 | - | - | - | |||
Series D Convertible Preferred Stock [Member] | ||||||
Issuance of convertible preferred stock, net of issuance costs | ||||||
- | - | - | 14,863 | |||
Series E Convertible Preferred Stock [Member] | ||||||
Issuance of convertible preferred stock, net of issuance costs | ||||||
- | - | 19,747 | - | |||